Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a fatal heterogeneous hematologic malignancy. There is an urgent need to identify potential biomarkers to better classify sufferers with bad outcomes that might need more advanced treatment. The objective of this study was to investigate prognostic indicators that pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuming, Wu, Weiqin, Han, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352173/
https://www.ncbi.nlm.nih.gov/pubmed/36479666
http://dx.doi.org/10.1007/s12033-022-00623-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352173/
https://www.ncbi.nlm.nih.gov/pubmed/36479666
http://dx.doi.org/10.1007/s12033-022-00623-9

Ejemplares similares